Search
Are New Therapies on the Horizon for Painful Skin Condition?
UCSF Health leads multi-center study of chronic inflammation of the skin that affects women and people of color disproportionately.Millions of Long-Term Smokers Have Lung Disease that Defies Diagnosis
Millions of Americans with tobacco-related lung disease have symptoms that do not fit any existing tobacco-related disease criteria – including the most common of those, chronic obstructive pulmonary disease (COPD)...Seizures Stopped, Speech Preserved After Rare Auditory Cortex Tumor is Removed: A UCSF Case Study
The extraordinary success was made possible through research on the neural mechanisms of speech by Edward Chang, MD, UCSF neurosurgeon and chair of the Department of Neurological Surgery, and an advanced phase 2 surgical evaluation by the UCSF Epilepsy Center team.Quantity of Body Fat, Rather Than Location, May Be Key for Cardiovascular Diseases
Increased obesity worldwide has become a leading cause of cardiovascular diseases. A new study by UC San Francisco and the Broad Institute of MIT and Harvard researchers found the the quantity of fat tissue rather than its location – either in the abomen or around the heart – was a greater determinant of cardiovascular disease risk.Low-Risk Differentiated Thyroid Cancer Case Studies: Patient-Centered Approaches to Treatment
A 2022 UCSF study found that, since publication of the 2015 American Thyroid Association (ATA) guidelines, surgeons nationwide are performing more thyroid lobectomies for low-risk differentiated thyroid cancer (DTC) proportional to other thyroid surgeries for the condition.Renal Cell Carcinoma Research Sheds New Light on Advanced Disease
In a recent study, UCSF researchers found that renal cell carcinoma (RCC)with venous tumor thrombus(VTT) does not always signify metastatic disease with poor prognosis. These findings provide insight into the development of advanced RCC and may help to better inform surveillance regimens and treatment decisions and, ultimately, improve clinical outcomes.Neuroendovascular Surgery
The newly formed Neuroendovascular Surgery program at UCSF offers accessible, coordinated care for even the most complex vascular disorders of the central nervous system.UCSF Research Instrumental in Approval of Breakthrough Diabetes Therapy
The US Food and Drug Administration (FDA) recently approved the use of a new drug Teplizumab, an immunotherapy drug which has been shown to significantly delay the onset of type 1 diabetes.Virtual Inpatient Diabetes Management Tools Minimize COVID-19 Risk for Staff and Improve Patient Outcomes
Automated virtual tools for inpatient diabetes management in use at UC San Francisco have helped the medical staff deliver safe and effective patient care while reducing their exposure to SARS-CoV-2.Novel Sequencing Test to Uncover Mystery Causes of Brain Inflammation Now Available at UCSF
Physicians seeking a cause for tough-to-diagnose cases of encephalitis or meningitis have a new tool in their arsenal, thanks to scientists at UC San Francisco’s Center for Next-Gen Precision Diagnostics.Drug Turns Cancer Gene Into "Eat Me" Flag for Immune System
UCSF-led study shows promising pre-clinical results in killing cancer cells resistant to current KRAS-targeted treatments.Advanced Heart Failure Clinic at Walnut Creek
Through a collaboration between John Muir Health and UCSF Health, patients with advanced heart failure have access to specialized care in Walnut Creek.UCSF Health Cancer Experts Featured at Premier Cancer Meeting
Oncology specialists from around the world came together for the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting to discuss the latest developments in cancer care, research, technology and education.UCSF Case Study: Same-Day Discharge After Pheochromocytoma Removal
San Francisco endocrine surgeon Sanziana Roman, MD, performed a posterior retroperitoneoscopic adrenalectomy (PRA) to remove a pheochromocytoma. This approach enabled the patient to be discharged home within hours of surgery and avoid prolonged hospitalization, thereby minimizing COVID-19 risk.Minimally Invasive LITT Effective for Recurrent Glioblastoma: A UCSF Case Study
A 65-year-old woman with a small focal recurrence of glioblastoma was treated with laser interstitial thermal therapy (LITT) at UCSF nearly five years after her first tumor resection surgery.Advancing Precision Medicine for Neuro-Oncology Patients: Q&A with David Solomon, MD, PhD
UC San Francisco neuropathologist and molecular neuro-oncologist David Solomon, MD, PhD has reached a unique and impressive milestone: the publication of his team's 50th neuro-oncology research study stemming from the UCSF500 Cancer Gene Panel, a molecular diagnostic test that identifies genetic changes in the DNA of a patient's cancer.Awake Spine Surgery
Shorter surgeries result in decreased lengths of stay, faster recovery times and less reliance on narcotics2019-20 Referral Services Guide
UCSF Health is recognized throughout the world for innovative treatments, advanced technology, collaboration among clinicians and scientists, and a highly compassionate team of patient care providers.Peripheral Artery Disease: Early Intervention, Limb Preservation and Clinical Trials at UCSF
September is Peripheral Artery Disease (PAD) Awareness Month. More than 200 million people worldwide are living with PAD, including more than 20 percent of people age 65 and older.Endoscopic Removal of Benign Complex Colorectal Lesions Improves Patient Outcomes
Endoscopic mucosal resection (EMR) is a safe and effective alternative to surgery for benign complex colorectal lesions, according to research led by UCSF gastroenterologist Tonya Kaltenbach, MD.UCSF Surgeons Standardize Browlift and Hairline Surgery Using Photo Analysis
Facial Feminization surgery (FFS) involves numerous procedures designed to give the face a more feminine and harmonious appearance.New Guidance on Using Biologics to Treat Chronic Rhinosinusitis with Nasal Polyps, Led by UCSF Clinician
Approximately 25 percent of people with chronic rhinosinusitis have nasal polyps, a condition associated with significant morbidity and decreased quality of life.UCSF Deploys Innovative Data System to Integrate Research and Care
UC San Francisco (UCSF), in collaboration with the Quantum Leap Healthcare Collaborative (QLHC) and the U.S. Food and Drug Administration (FDA) has developed the OneSource system to seamlessly integrate clinical care and research data.UCSF Lung Transplant Clinic in Roseville
UCSF Lung Transplant Clinic in Roseville